Monitor the upcoming definitive proxy statement for details on director elections and related proposals. The headquarters relocation is symbolic and does not signal immediate financial or operational changes.
Price Chart
Executive Summary
Provectus Biopharmaceuticals announced it will hold its 2026 Annual Meeting of Stockholders at Perkins Place, its planned new headquarters in Knoxville, Tennessee. The move marks a strategic relocation from its current offices and reflects the company's vision under CEO Ed Pershing's leadership.
Key Facts
- Provectus Biopharmaceuticals will hold its 2026 Annual Meeting on June 18, 2026, at Perkins Place in Knoxville, TN.
- Perkins Place is the company's planned new headquarters, replacing its current location at 800 S. Gay Street.
- The building has historical significance and personal ties to CEO Ed Pershing, who previously restored it for his prior firm.
- No financial figures, guidance, or material business developments were disclosed in the filing.
Financial Impact
No immediate financial impact disclosed. The relocation may provide long-term cost management benefits as stated in the press release.
Risk Factors
- Potential execution risk in the planned relocation to new headquarters.
- Delays or cost overruns associated with moving to the new facility could impact operations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-018160 |
| Exhibit: ex99-1.htm | 0001493152-26-018160 |
| Document: 0001493152-26-018160-index-headers.html | 0001493152-26-018160 |
| Document: 0001493152-26-018160-index.html | 0001493152-26-018160 |
| Document: 0001493152-26-018160.txt | 0001493152-26-018160 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 18, 2026 18w ago | 8-K | $0.0620 $0.0618 | ▼ −0.32% | ▲ +0.14% | $0.0490 (−20.97%) |
Apr 30, 2026 25w ago | DEFA14A | $0.0570 $0.0650 | ▲ +14.04% | ▲ +9.07% | $0.0490 (−14.04%) |
Apr 20, 2026 27w ago | 8-K | $0.0530 $0.0680 | ▲ +28.30% | ▲ +23.39% | $0.0490 (−7.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers